ARCALIS will exhibit at CPHI Americas, where CEO Dr.Takamatsu will also give a talk.
We will exhibit and deliver a presentation at the CPHI Americas, scheduled to be held from May 20th (Tue) to 22nd (Thu), Pennsylvania Convention Center in Philadelphia, PA, USA. We warmly invite you to visit our booth and presentation during the event.
【Event Details】https://www.cphi.com/americas/en/home.html
【Booth Information】
Date: May 20th (Tue) – 22nd (Fri)
Venue: Pennsylvania Convention Center, Philadelphia, PA, USA
Booth Number: 1715
Access: https://www.paconvention.com/attendees-1/travel-to-pa-convention-center
【Presentation】
Date: May 20th, 3:35 PM – 3:50 PM
Title: Building a Robust mRNA CDMO: Advancing Scalable and End-to-End Manufacturing Solutions
Presenter: Satoshi Takamatsu (Representative Director, President and CEO)
The demand for mRNA-based medicines and vaccines has surged in recent years, highlighting the need for a reliable, scalable, and end-to-end manufacturing ecosystem.
As a dedicated mRNA CDMO, ARCALIS is committed to enabling global access to high-quality mRNA therapeutics through cutting-edge production capabilities. In this session, we will explore the critical components of an integrated mRNA manufacturing platform, including template DNA production, mRNA synthesis, and LNP formulation. We will also discuss how strategic partnerships and advanced technologies are shaping the future of mRNA medicine manufacturing. Join us to gain insights into ARCALIS’ approach to accelerating innovation while ensuring regulatory compliance, scalability, and efficiency in mRNA therapeutic production.